Characterization of a panel of mouse single-chain antibodies against human recombinant interferon β1b

M. V. Pavlova(Taras Shevchenko National University of Kyiv), Pavlo Gilchuk(AstraZeneca (Japan)), O. V. Okunev(National Academy of Sciences of Ukraine), Yu. S. Nikolaiev(Taras Shevchenko National University of Kyiv), В. А. Кордюм, Д. М. Іродов(National Academy of Sciences of Ukraine)
Cytology and Genetics
August 1, 2008
10.3103/s0095452708040014
Cited by 1

Related Papers

Potently neutralizing and protective human antibodies against SARS-CoV-2
|Nature|2020|1.2k
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
|Cell Host & Microbe|2020|1.2k
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
|Nature Medicine|2021|1k
Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein
|Nature Medicine|2020|543
Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein
|Cell|2021|409